Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smart-Bioscience is a French biotechnology company specializing in the design and chemical synthesis of complex peptides and proteins. Based in the Grenoble region, the company utilizes its proprietary Chemical Protein Synthesis (CPS) platform to produce high-purity biomolecules that are often difficult to obtain through traditional recombinant methods. Their technology allows for the precise introduction of chemical modifications, such as site-specific labeling, non-natural amino acids, and post-translational modifications. Smart-Bioscience operates primarily as a contract research and manufacturing organization (CRO/CMO), supporting pharmaceutical and biotech clients in their drug discovery and development efforts. The company's expertise spans from initial design to the production of long peptides and small proteins for therapeutic and diagnostic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smart-Bioscience.